Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.

Florian Moik; Jakob Riedl; T Winder; Angelika Terbuch; CH Rossmann; Joanna Szkandera; Thomas Bauernhofer; Anne-Katrin Kasparek; Renate Schaberl-Moser; Andreas Reicher; Felix Prinz; Martin Pichler; Herbert Stöger; Michael Stotz; Armin Gerger; Florian Posch

doi:10.1038/s41598-019-42069-1

Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.

Florian Moik (First author)
, Jakob Riedl
, T Winder
, Angelika Terbuch
, CH Rossmann
, Joanna Szkandera
, Thomas Bauernhofer
, Anne-Katrin Kasparek
, Renate Schaberl-Moser
, Andreas Reicher
, Felix Prinz
, Martin Pichler
, Herbert Stöger
, Michael Stotz
, Armin Gerger
, Florian Posch^* (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Research article

23 Citations (Web of Science)

Original language	English
Journal	Scientific Reports
DOIs	https://doi.org/10.1038/s41598-019-42069-1
Publication status	Published - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

106 Biology
107 Other Natural Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine
303 Health Sciences
305 Other Human Medicine, Health Sciences

Research Fields

Cancer Research

DOI

10.1038/s41598-019-42069-1

Links

Cite this

Moik, F., Riedl, J., Winder, T., Terbuch, A., Rossmann, CH., Szkandera, J., Bauernhofer, T., Kasparek, A.-K., Schaberl-Moser, R., Reicher, A., Prinz, F., Pichler, M., Stöger, H., Stotz, M., Gerger, A., & Posch, F. (2019). Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis. Scientific Reports. https://doi.org/10.1038/s41598-019-42069-1

@article{bfed5ef3d5f84de391c3bfb35e0ee28c,

title = "Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.",

author = "Florian Moik and Jakob Riedl and T Winder and Angelika Terbuch and CH Rossmann and Joanna Szkandera and Thomas Bauernhofer and Anne-Katrin Kasparek and Renate Schaberl-Moser and Andreas Reicher and Felix Prinz and Martin Pichler and Herbert St{\"o}ger and Michael Stotz and Armin Gerger and Florian Posch",

year = "2019",

doi = "10.1038/s41598-019-42069-1",

language = "English",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Research",

}

Moik, F , Riedl, J, Winder, T, Terbuch, A, Rossmann, CH, Szkandera, J , Bauernhofer, T, Kasparek, A-K, Schaberl-Moser, R, Reicher, A, Prinz, F, Pichler, M, Stöger, H , Stotz, M, Gerger, A & Posch, F 2019, 'Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.', Scientific Reports. https://doi.org/10.1038/s41598-019-42069-1

TY - JOUR

T1 - Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.

AU - Riedl, Jakob

AU - Winder, T

AU - Terbuch, Angelika

AU - Rossmann, CH

AU - Szkandera, Joanna

AU - Bauernhofer, Thomas

AU - Kasparek, Anne-Katrin

AU - Schaberl-Moser, Renate

AU - Reicher, Andreas

AU - Prinz, Felix

AU - Pichler, Martin

AU - Stöger, Herbert

AU - Stotz, Michael

AU - Gerger, Armin

A2 - Moik, Florian

A2 - Posch, Florian

PY - 2019

Y1 - 2019

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000463178500009

UR - https://pubmed.ncbi.nlm.nih.gov/30944390

UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC6447553

U2 - 10.1038/s41598-019-42069-1

DO - 10.1038/s41598-019-42069-1

M3 - Research article

C2 - 30944390

SN - 2045-2322

JO - Scientific Reports

JF - Scientific Reports

ER -